NCT02312986View on ClinicalTrials.gov

FMT for Multidrug Resistant Organism Reversal

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Infection With Multi-drug Resistant Organisms
Interventions
BIOLOGICAL

Fecal microbiota transplantation (FMT)

Prospective pilot study to examine whether fecal microbiota transplantation (FMT) is able to suppress or reverse gastrointestinal carriage of multi-drug resistant organisms.

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02312986 - FMT for Multidrug Resistant Organism Reversal | Biotech Hunter | Biotech Hunter